Mr. Cluff will report to CEO Patrick Johnson, the inventor of the Celluma.

Curtis Cluff is the new President and Chief Financial Officer BioPhotas Inc., manufacturers of the Celluma series of light therapy devices.

In this newly created role, Mr. Cluff will report to Patrick Johnson, Chief Executive Officer and inventor of the Celluma.

"Curtis brings more than 20 years of industry leadership experience building or creating several successful aesthetic medical and consumer skincare brands,” says Johnson in a news release. “Most recently, Curtis has served as the CEO for WalDin, developing a global retail presence for their Mila Moursi Paris Luxury skincare brand."

Mr. Cluff was CEO of Envy Medical. Other previous roles include President/COO for Colorescience Inc. as well as a number of executive roles for Obagi Medical Products, Inc.  He began his career as a CPA with Deloitte and has a degree in Business Administration from California Polytechnic University. 

"I am very excited to join such an accomplished team that is dedicated to improving quality of life on such a global scale," says  Mr. Cluff. "With FDA clearance in four major market segments to date and more to come, the Celluma is a phenomenal treatment platform in the professional channel, and very attractive at-home consumer applications."